Intrinsic Value of S&P & Nasdaq Contact Us

CME Group Inc. CME NASDAQ

NASDAQ Global Select • Financial Services • Financial - Data & Stock Exchanges • US • USD

SharesGrow Score
75/100
5/7 Pass
SharesGrow Intrinsic Value
$271.54
-8.6%
Analyst Price Target
$311.83
+5%

CME Group Inc. (CME) generated $4.28B in operating cash flow for fiscal year 2025. After capital expenditures of $83.5M, free cash flow was $4.19B.

Free cash flow margin was 64.3% of revenue. Cash conversion ratio was 1.06x, indicating earnings are backed by cash.

The company returned $3.93B in dividends and $266.1M in share buybacks to shareholders during the period.

Criteria supported by this page:

  • HEALTH (100/100, Pass) — demonstrate the company can comfortably service its debt
  • MOAT (82/100, Pass) — $4.19B (64.3% FCF margin) supports a durable competitive advantage
  • INCOME (100/100) — Cash conversion ratio was 1.06x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 75/100 with 5/7 criteria passed.

SharesGrow 7-Criteria Score
75/100
SG Score
View full scorecard →
VALUE
33/100
Price-to-Earnings & upside
→ Valuation
~
FUTURE
40/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
82/100
Proven by this page
GROWTH
73/100
→ Income
INCOME
100/100
→ Income
CME Group Inc. Cash Flow History
Metric TTM FY2025 FY2024 FY2023 FY2022
Operating Cash Flow $4.28B$4.28B$3.69B$3.45B$3.06B
Capital Expenditure $-69.3M$-83.5M$0.00$-76.4M$-89.7M
Free Cash Flow $4.19B$4.19B$3.6B$3.38B$2.97B
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message